BioLife Solutions, Inc. Other Restructuring Costs
BioLife Solutions, Inc. (BLFS) reported Other Restructuring Costs of $1.55 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2025-11-06
- BioLife Solutions, Inc. other restructuring costs for the quarter ending 2025-09-30 was $0.00.
- BioLife Solutions, Inc. other restructuring costs for the quarter ending 2025-06-30 was $0.00.
- BioLife Solutions, Inc. other restructuring costs for the quarter ending 2025-03-31 was $1.55M.
- BioLife Solutions, Inc. other restructuring costs for the quarter ending 2024-09-30 was $0.00.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $1.55M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.55M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.55M 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.55M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.55M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |